{
    "2020-07-28": [
        [
            {
                "time": "2020-07-27",
                "original_text": "'I feel quite confident that we can execute this': Pfizer CSO on COVID-19 vaccine",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "CSO",
                        "COVID-19",
                        "vaccine",
                        "confident"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-07-27",
                "original_text": "Coronavirus update: Pfizer starts Phase 3 trial as Fauci voices optimism on vaccine timeline",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "Pfizer",
                        "Phase 3",
                        "trial",
                        "Fauci",
                        "optimism",
                        "vaccine"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-07-27",
                "original_text": "Pfizer begins COVID-19 vaccine phase 3 trial",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "COVID-19",
                        "vaccine",
                        "phase 3",
                        "trial"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-07-13",
                "original_text": "TSMC Pares Gains After $72 Billion Surge to Start the Week",
                "features": {
                    "keywords": [
                        "TSMC",
                        "Gains",
                        "$72 Billion",
                        "Surge",
                        "Start the Week"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}